Related Experiment Video
Updated: Sep 11, 2025

08:25
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
6.8K
Advancing Genotoxicity Assessment by Building a Global AOP Network
E Demuynck1,2, T Vanhaecke2, A Thienpont1
1Scientific Direction of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium.
Environmental and Molecular Mutagenesis
|August 11, 2025
Summary
Modernizing genotoxicity testing requires Integrated Approaches for Testing and Assessment (IATAs). These frameworks use New Approach Methodologies (NAMs) to improve accuracy and reduce animal use.
Area of Science:
- Toxicology
- Genetics
- Regulatory Science
Background:
- Current genotoxicity testing faces challenges like misleading results and limited mechanistic insights.
- Existing testing batteries lack integration of advanced technologies and quantitative assessment.
- There's a need to reduce reliance on animal testing in genotoxicity assessment.
Purpose of the Study:
- To explore challenges in European regulatory frameworks for genotoxicity assessment.
- To discuss the development and implementation of Integrated Approaches for Testing and Assessment (IATAs) for genotoxicity.
- To present a global Adverse Outcome Pathway (AOP) network for DNA damage to guide IATA development.
Main Methods:
- Review of current genotoxicity testing strategies and regulatory frameworks.
- Exploration of New Approach Methodologies (NAMs) like 3D systems, ToxTracker, and transcriptomic biomarkers.
- Application of the Adverse Outcome Pathway (AOP) framework to integrate NAMs into IATAs.
Main Results:
- Identified key challenges and gaps in current genotoxicity assessment, particularly within European regulations.
- Highlighted the potential of NAMs and AOPs to create more accurate and efficient genotoxicity testing.
- Proposed a global AOP network for permanent DNA damage to support regulatory decision-making.
Conclusions:
- IATAs integrating NAMs, guided by AOPs, are essential for modernizing genotoxicity assessment.
- This approach can enhance accuracy, efficiency, and ethical standards while reducing animal testing.
- The proposed AOP network offers a framework for improved regulatory decision-making in chemical safety assessment.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K

